NTRB
Price
$9.91
Change
-$0.81 (-7.56%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
118.76M
90 days until earnings call
SONN
Price
$3.92
Change
-$0.23 (-5.54%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
3.83M
Interact to see
Advertisement

NTRB vs SONN

Header iconNTRB vs SONN Comparison
Open Charts NTRB vs SONNBanner chart's image
Nutriband
Price$9.91
Change-$0.81 (-7.56%)
Volume$2.33K
Capitalization118.76M
Sonnet BioTherapeutics Holdings
Price$3.92
Change-$0.23 (-5.54%)
Volume$7.47K
Capitalization3.83M
NTRB vs SONN Comparison Chart in %
Loading...
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NTRB vs. SONN commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRB is a StrongBuy and SONN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (NTRB: $10.67 vs. SONN: $4.16)
Brand notoriety: NTRB and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTRB: 1718% vs. SONN: 4530%
Market capitalization -- NTRB: $118.76M vs. SONN: $3.83M
NTRB [@Biotechnology] is valued at $118.76M. SONN’s [@Biotechnology] market capitalization is $3.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRB’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • NTRB’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, NTRB is a better buy in the long-term than SONN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRB’s TA Score shows that 4 TA indicator(s) are bullish while SONN’s TA Score has 5 bullish TA indicator(s).

  • NTRB’s TA Score: 4 bullish, 4 bearish.
  • SONN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both NTRB and SONN are a good buy in the short-term.

Price Growth

NTRB (@Biotechnology) experienced а +38.57% price change this week, while SONN (@Biotechnology) price change was +268.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

NTRB is expected to report earnings on Oct 01, 2025.

SONN is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRB($119M) has a higher market cap than SONN($3.83M). SONN YTD gains are higher at: 184.925 vs. NTRB (126.539). NTRB has higher annual earnings (EBITDA): -9.68M vs. SONN (-13.69M). NTRB has more cash in the bank: 2.96M vs. SONN (2.06M). SONN has less debt than NTRB: SONN (90.4K) vs NTRB (282K). NTRB has higher revenues than SONN: NTRB (2.4M) vs SONN (1M).
NTRBSONNNTRB / SONN
Capitalization119M3.83M3,106%
EBITDA-9.68M-13.69M71%
Gain YTD126.539184.92568%
P/E RatioN/A0.29-
Revenue2.4M1M240%
Total Cash2.96M2.06M144%
Total Debt282K90.4K312%
FUNDAMENTALS RATINGS
NTRB vs SONN: Fundamental Ratings
NTRB
SONN
OUTLOOK RATING
1..100
3345
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3764
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SONN's Valuation (52) in the null industry is in the same range as NTRB (79). This means that SONN’s stock grew similarly to NTRB’s over the last 12 months.

NTRB's Profit vs Risk Rating (91) in the null industry is in the same range as SONN (100). This means that NTRB’s stock grew similarly to SONN’s over the last 12 months.

NTRB's SMR Rating (98) in the null industry is in the same range as SONN (100). This means that NTRB’s stock grew similarly to SONN’s over the last 12 months.

NTRB's Price Growth Rating (37) in the null industry is in the same range as SONN (64). This means that NTRB’s stock grew similarly to SONN’s over the last 12 months.

SONN's P/E Growth Rating (97) in the null industry is in the same range as NTRB (100). This means that SONN’s stock grew similarly to NTRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRBSONN
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 23 days ago
87%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NTRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REOP36.001.50
+4.35%
Reo Plastics, Inc.
MXGBF51.16N/A
N/A
Molson Coors CDA Inc.
NCCGF2.25N/A
N/A
NCC Group Plc, Manchester
RKNEF1.16N/A
N/A
Optiva Inc.
WAWIF7.90-0.10
-1.25%
Wallenius Wilhelmsen ASA

NTRB and

Correlation & Price change

A.I.dvisor tells us that NTRB and VRAX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NTRB and VRAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRB
1D Price
Change %
NTRB100%
+33.04%
VRAX - NTRB
31%
Poorly correlated
+2.37%
SONN - NTRB
29%
Poorly correlated
+235.48%
REPL - NTRB
27%
Poorly correlated
+4.43%
RARE - NTRB
27%
Poorly correlated
+8.84%
SYRE - NTRB
27%
Poorly correlated
N/A
More

SONN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONN has been loosely correlated with LIXT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SONN jumps, then LIXT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
+235.48%
LIXT - SONN
40%
Loosely correlated
+76.27%
NTRB - SONN
29%
Poorly correlated
+33.04%
MCRB - SONN
27%
Poorly correlated
+1.45%
DWTX - SONN
27%
Poorly correlated
-2.42%
RARE - SONN
26%
Poorly correlated
+8.84%
More